ABSTRACT
A total of 34 indigenously manufactured
pharmaceutical oral liquids were purchased from different potent medicine
stores in Owerri main market from August to October. They were examined
microbiologically to ascertain the common contaminants associated with them.
The result of analysis showed that Staphylococcus species, Escherichia
Coli and Pseudomonas are the main contaminants of these oral
liquids.
While Bacillus spp and klebsiella
were also identify, paracetamol syrup and emcap were found to meet the standard
of B.P while bonagyl and parkalin did not meet the standard, and hence not safe
for use in any treatment.
TABLE OF CONTENTS
CHAPTER
ONE
1.0
Introduction
1.2
Factors important in determining the rate at which a drug is absorbed from its
site of administration are
1.3
Effect of microorganisms on drugs
1.4
Systemic availability of drug
1.5
Raw materials
1.6
Water supply
1.7
Air
1.8
Equipment
1.9
Personnel
1.10
Containers/packaging materials
CHAPTER TWO
2.0
Literature review
CHAPTER THREE
3.0
Materials and methods
3.1
Sterilization of materials and aseptic techniques
3.2
Pharmaceutical industry visited
3.3
Collection of samples
3.4
Preparation of media
3.5
Analysis of the samples
3.6
Sub culturing of samples
3.7
Isolation of bacterial on selective media
3.8
Identification of isolates
3.9
Method of preparation of media
3.10
Gram’s-staining
3.11
Catalase test
3.12
Indole test
3.13
Motility test
13.14
Methyl red test
3.15
Voges proskauer test
3.16
Sugar fermentation test
3.17
Triple sugar iron agar (TSI)
3.18
Colonial and cellular characteristics of organisms isolated in drul4g sample on
different media
CHAPTER FOUR
4.0
Discussion and Conclusion
Conclusion
Recommendations
References
CHAPTER ONE
1.0 INTRODUCTION
ENUMERATION OF MICROORGANISMS IN PHARMACEUTICAL
ORAL LIQUIDS.
Pharmaceutical
oral liquids — syrups or suspensions are among the numerous pharmaceutical
products and have different compositions and diversity of contaminating
microorganisms, each with its specific application and problems, some products
are however more imperiled to be contaminated with microorganisms and they are
more hazardous than other ones.
We
have seen a number of problems associated with the microbiological
contamination of tropical drug products, nasal solutions and inhalation
products (
Pharmaceutical
products such as liquids (syrups) are generally required to be sterile;
however, it is desirable that, they contain low level of microbial
contamination in the biodegradation of the products which in essence,
constitute a health hazard to its consumers. The most important
component
of the living matter is water. Multiplication and survival of microorganisms in
drugs. This reports emphasized the need to monitor the microbiological quality
on non-sterile pharmaceutical products, dispensed and sold in the public
hospitals, pharmacies and potent medicine stores Taylor, R. B; Behrens, and
low, A. S (2001).
ORAL LIQUIDS:
They are homogenous liquids preparations, usually consisting of a solution, a
suspension or emulsion of suitable vehicle which are more active to be
swallowed either undiluted or after dilution. Oral liquids may contain
auxiliary substance such as suitable antimicrobial preservatives dispensing,
suspending, emulsifying, stabilizing, flavouring, colouring and sweeten agents.
The vehicle for any particular oral liquid should be chosen having regard to be
nature of the active ingredients and to produce organoleptic characteristics
appropriate to the intended se of the preparation.
ORAL SUSPENSION:
Are oral liquids containing one or more active ingredients suspended in
suitable vehicle.
Suspended
solid may slowly separate on standing but are easily redispened.
ORAL DROP:
Are oral liquid that are intended to be administered in small volume in the aid
of a suitable measuring device.
MIXTURE:
Are oral liquids containing one or more active ingredient dissolved, suspended
or dispersed in a suitable
vehicle.
Suspended solids may separate slowly on standing but easily redispersed on
shaking.
ORAL SOLUTIONS:
Are oral liquids containing one or more active ingredients dissolved in a
suitable vehicle.
ELIXIRS:
Are oral liquids that contains one or more active ingredients dissolved in a
vehicle that usually contains a high proportion of sucrose or a suitable
polyhydric alcohol or alcohols and may also contains ethanol (96%) or a dilute
ethanol.
LINCTUSES:
Are viscous oral liquids that may contain one or more active ingredients in
solution.
The
vehicle usually contain large amount of sucrose or alcohols. Linctuses are
intended for use in the treatment or relief of cough being sipped and swallowed
slowly count and addition of water.
ORAL EMULSIONS: Are
oral liquids containing one or more active ingredient. They are stabilized
oil-in-water dispersions, either or both phases of which may contain dissolved
solids. Solid may also be suspended in oral emulsions.
In
oral emulsions prepared according to the formular and directions given for
extemporaneous preparation and quantity of emulsifying agent specified in
individual monographs may be consistence provided by doing and stability of the
preparation in not affected when in uses, oral emulsions should be supplied.
1.2 FACTORS IMPORTANT IN DETERMINING
THE RATE AT WHICH A DRUG IS ABSORBED FROM ITS SITE OF ADMINISTRATION ARE
a.
Dosage form
b.
Solubility in the tissue in which it is placed
c.
Blood flow through the tissue
(Laurence,
D. R. and Bennett, P.N 1987)
Definitions of drug:
World Health Organization (WHO) define drug as “any substance or product that
is used or intended to be used to modify or explore physiological systems or
pathological states for the benefit of the recipient
(WHO
1988).
A
drug is a simple chemical substance that forms the active ingredient of a
medicine, which latter may contain many other substances to deliver the drug in
a stable form, acceptable and convenient to patient (Laurence D. R. and Bennett
P. N 1987).
Drug
should be selectively toxic meaning they should kill or inhibit microbial cells
without simultaneously damaging host tissue. Best drug are those that block the
actions or synthesis of molecules in microorganisms but not in vertebrate
cells.
1.3 EFFECT OF MICRORGANISMS ON DRUGS
Example
is drugs with selective toxicity are those that block the synthesis of the cell
walls in bacteria (penicillin). They have low toxicity and few direct effects
on human cells because cells lack a wall and are thus natural to these actions
of the antibiotic. Among the most toxic to human cells are drugs that act upon
a structure common to both the ineffective agent and the host cell such as the
cell membrane (Kathlene P. T. 2005).
PHARMACOLOGISTS
(one who specialize in the scientific study of drugs and their uses in medicine)
say that drug comprises two broad divisions.
A.
PHARMACODYNAMICS: The biological and
therapeutic
effect of drugs ie. What drug dose in the body.
B.
PHARMACOKINETICS: Absorption, distribution,
metabolism
and excretion of drugs ie. What the body does to the drugs (Laurence D. R. and
Bennett P. N, 1987).
1.4 SYSTEMIC AVAILABILITY OF DRUG
When
drug is injected intravenously, it gains access to the systemic circulation and
hence to the tissue and receptor ie. 100% s a available to exert its
therapeutic effect, if the same quantity of drug is swallowed, it does not
follow that the entire amount will reach first the portal blood and then the
systemic blood that is its availability for therapeutic effect may be less than
100%. The anticipated response to drug may not be achieved unless biological
availability is taken into account. In a sense, consideration of drugs that are
slowly absorbed. Drugs may also bind to food constituents eg. Tetracycline to
calcium and to iron, or to other drugs e.g. Acidic drug to reduced availability
apply whenever any drug intended for systemic effect given by
any
other route rather than the intravenous, but in practice the tissue concerns
enteral administration. This may be thought in three ways:
I. Pharmaceutical
(Drug/Medicine) Factor:- The amount of drug that is released
from a dose form is highly dependant on its formulations. Manufacturers are
expected to produce a formulation with an unvarying biological availability
(Bio-availability) so that the same amount of drug is released with the same
speed from whatever band the patients may be taking e.g. with syrups, particle
size, surface area exposed to solution) diluting substances, syrup size and
pressure used in the machine may effect the disintegration and dissolution and so
the biological availability of drug is difference in biological which can be
demonstrated if different blood concentration of the same amount of drug are
given to a single individual one after another but in manufacturing practice,
measurement of the time a syrups takes to mixture up in water (disintegration
time) are used to check consistency of different batches. Cowan, S. T. and
Stanley (1994).
2. Biological factors:-
It relates to the guts. These include destruction of drug by gastric acid e.g.
benzyl penicillin and impaired absorption due to intestinal which is important
for all drugs that are slowly absorbed.
3. Pre- systemic elimination or
hepatic effect: Despite the fact that they pas rapidly
through the gut mucosal cell membrane, some drugs appear in low concentration
in the systemic circulation. The reason lies in the considerable extent to
which such drugs are metabolized in a single passage through the gut wall and
liver and an important feature of the oral route is that all drugs that is
absorbed cannot escaped these elimination processes. As little as 10-20% of the
parent drug may reach the systemic circulation unchanged. By contrast, if the
same dose is given intravenously, 100% is systematically available and the
patient is exposed to higher concentrations with great effect once the drug is
in systemic circulation, irrespective of which route is used, about 20% is
subjected to hepatic metabolic process in each circulation because that is the
proportion of cardia output that supplies the liver i.e. Blood flow (main
determinate of metabolism). (Laurence D. R. and Bennett P. N. 1987).
Considerations
in selecting an antimicrobic drug before actual antimicrobic therapy can begin.
It is important that at least three factors are known.
1.
The nature of the microorganism causing the infection.
2.
The degree of the microorganisms susceptibility (also called sensitivity) to
various drugs and
3.
The overall medical condition of the patient (Kathlen P. Talaro 2005).
Some
syrups and solutions contain preservatives and sugar concentrations, which
suppress the growth of most microorgarisms except the osmotolerant one (Grigo
1976). Because of their low water content, liquids are normally protected
against microbial growth but are sometimes attached by some microorganisms and
fungi especially when mixed with sweat, which act as a good nutrient medicine
for them. Liquids (syrups) do not allow excessive microbial multiplication
after manufacturing because of their low water activity except when exposed to
air or during dispersing. Under bad storage conditions, a local increase of
water content may permit microbial growth. This trend is not seen in the cases
of not using multi-dose containers for injections because of the high risks of
contamination. (Water man, R. R) Sumner, E.D Baldwinz J. N 2001).
Microbiological
qualities of pharmaceutical products are influenced by the environment in which
they are manufactured, packaged/handled and dispensed, and also the materials
used in their production (Farero, et al 1989).
1.5 RAW MATERIALS
The
source of raw materials used in the production of the various pharmaceutical
products determine the level of microbial contamination. Raw materials of
animals and vegetable origin were repeatedly shown to be contaminated with
viable organisms and molds, which can render a preparation objectionable or
even dangerous (chamber, et al; 1988).
However,
irradiation is being used to endure that the hygienic quality of this product
in
1.6 WATER SUPPLY
This
plays an important role in pharmacy formations being the source of many
potential harmful organisms, especially the coliforms and the same time
providing medium for the growth of organisms introduced from other sources. The
microorganisms frequently encountered are bacteria, fungi, algae and protozoa
(Chukwura 2001). Even treated or distilled water can still readily pick up
organism from pipe and storage containers without effective treatment to
minimize contaminations.
1.7 AIR
Air
can harbour large numbers of microorganisms particularly the sporulating
bacteria such as clostricdium species, the non-sporing bacteria and the
molds, such as penicillium spp, cladosporium species, aspergillus
species and mucor as well as yeast, such as Rhodoturola species
(Underwood, al; 1983).
Microorganisms
are carried into the atmosphere suspended in particle of dusts, talking,
coughing, sneezing. These organisms can survive for a long period of time since
they are usually protected by the dust particle; the number in the air depends
on the activity in the environment and the amount of dust which is disturbed
and also its humidity
(Remington’s
pharmasc. 1992).
1.8 EQUIPMENT
Apparatus
and machines in the manufacture of various non-sterile pharmaceutical products
and those used in dispensing may harbour microorganisms which might growth in
the product. Therefore it is important to eliminate such microbial reservoir by
sterilization to prevent them from contaminating subsequent products.
1.9 PERSONNEL
Human
beings may harbour various organisms in their respiratory tnacts, intestinal
canal, on the skin, on their hairs and even in the finger nails. The nasal
passages may contain large numbers of organisms which are secreted during
normal respiratory function and speech (Underwood et al 1983).
They
may also contaminate these products thoughts through handling of strict
personal hygiene in not observed. Therefore, t is very important that all
employees in pharmaceutical industries should be given an adequate training in
fundamental personal hygiene and also protective measures like nose masks and
hand gloves should be used both in manufacturing and dispensing of these products
to minimize contaminations. Khante,
S.
B (1992).
1.1O CONTAINERS/PACKAGING MATERIALS
Containers
for syrups should be well sterilized; the products should be properly checked
to know if there is any leakage. The microflora in the final product may
represent contaminatloeri from the raw materials or the equipment with which it
was made, air or from operator.
The
aim of this study therefore, is to investigate the incidence of microflora in
syrups especially those dispensed from large containers/packages. The data
obtained herein, would provide information of the extent and nature of
microbial contamination of these products, which would inevitably assist in
determining and controlling the source of such contamination in future.
Department | Science Lab Technology |
Project ID Code | SLT0004 |
Chapters | 5 Chapters |
No of Pages | 50 pages |
Methodology | Null |
Reference | YES |
Format | Microsoft Word |
Price | ₦4000, $15 |
|
|
Contact Us On | +2349067372103 |
Contact Us On | +2349094562208 |
|